Clinical Trial Update: 123I-MIBG SPECT/CT for Assessment of Cardiac Sympathetic Innervation

View source ↗

Summary

A clinical trial evaluating 123I-MIBG SPECT/CT for assessing cardiac sympathetic innervation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Metaiodobenzylguanidine (MIBG) (meta-iodobenzylguanidine (MIBG))

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Cardiac Diseases | Status: COMPLETED